Block Earnings: Cash App Drives a Beat and a Third Straight Guidance Raise
Block earnings: Q3 adjusted EPS of $1.13 and $3.24 billion gross profit beat forecasts; Block raised its 2026 outlook and set a $14.52 billion 2027 goal.
Earnings
Novo Nordisk Earnings: Wegovy Pill Beats Forecasts as Novo Raises Outlook
Novo Nordisk earnings: Q3 sales of 79.2 billion kroner beat forecasts as the Wegovy pill took in 5.4 billion, and Novo raised its 2026 outlook. Data inside.
Supermicro Earnings: Sales Nearly Quadruple to $19.9 Billion, but Margins Thin
Supermicro earnings: fiscal Q1 sales hit $19.9 billion, up 298%, and the 2027 outlook rose to $72-82 billion, but gross margin fell to 12.7%. Data inside.
CVS Health Split: Drugstores to Become Their Own Company as Aetna Profit Nearly Triples
CVS Health split: CVS will spin off its 9,000 drugstores as CVS Pharmacy by 2028 as Q3 revenue hits $108.4 billion and it raises 2026 guidance. Data inside.
Flywire Revenue Jumps 25% to $250 Million as Boston Payments Firm Raises 2026 Outlook
Boston-based Flywire’s Q3 revenue rose 25.1% to $250.3 million on $17.8 billion in payment volume, and it raised its 2026 growth outlook to 25%-27%.
Vertex Raises 2026 Forecast on $3.44 Billion Quarter as Crinetics Costs Cut Profit 40%
Vertex’s Q3 revenue rose 12% to $3.44 billion as Alyftrek sales nearly tripled, and it raised its 2026 forecast. Crinetics deal costs cut GAAP profit 40%.